Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jan 1;2(1):15-22.
doi: 10.7150/jbji.16934. eCollection 2017.

Use of Chlorhexidine Preparations in Total Joint Arthroplasty

Jaiben George  1 , Alison K Klika  1 , Carlos A Higuera  1
Affiliations
Review

Use of Chlorhexidine Preparations in Total Joint Arthroplasty

Jaiben George et al. J Bone Jt Infect. .

Abstract

Prosthetic joint infection (PJI) is a serious complication after total joint arthroplasty (TJA). Chlorhexidine is a widely used antiseptic because of its rapid and persistent action. It is well tolerated and available in different formulations at various concentrations. Chlorhexidine can be used for pre-operative skin cleansing, surgical site preparation, hand antisepsis of the surgical team and intra-articular irrigation of infected joints. The optimal intra-articular concentration of chlorhexidine gluconate in irrigation solution is 2%, to provide a persistent decrease in biofilm formation, though cytotoxicity might be an issue. Although chlorhexidine is relatively cheap, routine use of chlorhexidine without evidence of clear benefits can lead to unnecessary costs, adverse effects and even emergence of resistance. This review focuses on the current applications of various chlorhexidine formulations in TJA. As the treatment of PJI is challenging and expensive, effective preparations of chlorhexidine could help in the prevention and control of PJI.

Keywords: Prosthetic joint infection; total joint arthroplasty.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interest exists.

References

    1. Jämsen E, Furnes O, Engesaeter LB, Konttinen YT, Odgaard A, Stefánsdóttir A. et al. Prevention of deep infection in joint replacement surgery. Acta Orthop. 2010;81:660–6. doi:10.3109/17453674.2010.537805. - PMC - PubMed
    1. Kapadia BH, Berg RA, Daley JA, Fritz J, Bhave A, Mont MA. Periprosthetic joint infection. Lancet (London, England) 2016;387:386–94. doi:10.1016/S0140-6736(14)61798-0. - PubMed
    1. Odum SM, Springer BD, Dennos AC, Fehring TK. National obesity trends in total knee arthroplasty. J Arthroplasty. 2013;28:148–51. doi:10.1016/j.arth.2013.02.036. - PubMed
    1. Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty. 2008;23:984–91. doi:10.1016/j.arth.2007.10.017. - PubMed
    1. Trampuz A, Widmer AF. Infections associated with orthopedic implants. Curr Opin Infect Dis. 2006;19:349–56. doi:10.1097/01.qco.0000235161.85925.e8. - PubMed